Do analysts prefer HYPD or TROO?

Hyperion DeFi currently has a consensus price target of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher possible upside, research analysts plainly believe Hyperion DeFi is more favorable than TROOPS. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperion DeFi 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 TROOPS 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, HYPD or TROO?

TROOPS has higher revenue and earnings than Hyperion DeFi. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hyperion DeFi $810K 60.43 -$45.31M -$6.53 N/A TROOPS $17.10M 11.50 -$27.91M N/A N/A

Do analysts recommend HYPD or MAAS?

Hyperion DeFi presently has a consensus target price of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher probable upside, equities analysts clearly believe Hyperion DeFi is more favorable than Maase. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperion DeFi 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Maase 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, HYPD or MAAS?

Maase has higher revenue and earnings than Hyperion DeFi. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hyperion DeFi $810K 60.43 -$45.31M -$6.53 N/A Maase $109.05M 1.84 -$27.36M N/A N/A

Is HYPD or MAAS more profitable?

Hyperion DeFi has a net margin of 416.56% compared to Maase's net margin of 0.00%. Maase's return on equity of 0.00% beat Hyperion DeFi's return on equity. Company Net Margins Return on Equity Return on Assets Hyperion DeFi 416.56% -11.62% -9.96% Maase N/A N/A N/A

Do analysts prefer HYPD or TONX?

Hyperion DeFi presently has a consensus price target of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher probable upside, analysts clearly believe Hyperion DeFi is more favorable than Verb Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperion DeFi 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Verb Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer HYPD or CNTN?

Hyperion DeFi presently has a consensus price target of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher possible upside, equities analysts plainly believe Hyperion DeFi is more favorable than Hillstream Biopharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperion DeFi 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Hillstream Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is NAKA or HYPD more profitable?

Hyperion DeFi has a net margin of 416.56% compared to KindlyMD's net margin of -1,067.93%. Hyperion DeFi's return on equity of -11.62% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -1,067.93% -63.45% -41.04% Hyperion DeFi 416.56% -11.62% -9.96%

Hyperion DeFi (HYPD) Competitors

$2.84 -0.31 (-9.84%)

Closing price 04:00 PM Eastern

Extended Trading

$2.90 +0.06 (+2.29%)

As of 07:45 PM Eastern

Compare

HYPD vs. TROO, MAAS, TONX, CNTN, and NAKA

Should you buy Hyperion DeFi stock or one of its competitors? Hyperion DeFi's main competitors and comparable companies include TROOPS (TROO), Maase (MAAS), Verb Technology (TONX), Hillstream Biopharma (CNTN), and KindlyMD (NAKA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does Hyperion DeFi compare to TROOPS?

Hyperion DeFi (NASDAQ:HYPD) and TROOPS (NASDAQ:TROO) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

25.8% of Hyperion DeFi shares are owned by institutional investors. 7.5% of Hyperion DeFi shares are owned by company insiders. Comparatively, 1.1% of TROOPS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

TROOPS has higher revenue and earnings than Hyperion DeFi.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$810K	60.43	-$45.31M	-$6.53	N/A
TROOPS	$17.10M	11.50	-$27.91M	N/A	N/A

Hyperion DeFi currently has a consensus price target of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher possible upside, research analysts plainly believe Hyperion DeFi is more favorable than TROOPS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
TROOPS	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hyperion DeFi has a net margin of 416.56% compared to TROOPS's net margin of 0.00%. TROOPS's return on equity of 0.00% beat Hyperion DeFi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-11.62%	-9.96%
TROOPS	N/A	N/A	N/A

Hyperion DeFi has a beta of 2.51, suggesting that its share price is 151% more volatile than the broader market. Comparatively, TROOPS has a beta of 3.51, suggesting that its share price is 251% more volatile than the broader market.

In the previous week, TROOPS had 19 more articles in the media than Hyperion DeFi. MarketBeat recorded 20 mentions for TROOPS and 1 mentions for Hyperion DeFi. Hyperion DeFi's average media sentiment score of 0.60 beat TROOPS's score of -0.29 indicating that Hyperion DeFi is being referred to more favorably in the media.

Company	Overall Sentiment
Hyperion DeFi	Positive
TROOPS	Neutral

Summary

Hyperion DeFi beats TROOPS on 8 of the 14 factors compared between the two stocks.

How does Hyperion DeFi compare to Maase?

Hyperion DeFi (NASDAQ:HYPD) and Maase (NASDAQ:MAAS) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

25.8% of Hyperion DeFi shares are held by institutional investors. 7.5% of Hyperion DeFi shares are held by company insiders. Comparatively, 87.6% of Maase shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Maase has higher revenue and earnings than Hyperion DeFi.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$810K	60.43	-$45.31M	-$6.53	N/A
Maase	$109.05M	1.84	-$27.36M	N/A	N/A

Hyperion DeFi has a beta of 2.51, suggesting that its stock price is 151% more volatile than the broader market. Comparatively, Maase has a beta of 0.11, suggesting that its stock price is 89% less volatile than the broader market.

Hyperion DeFi has a net margin of 416.56% compared to Maase's net margin of 0.00%. Maase's return on equity of 0.00% beat Hyperion DeFi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-11.62%	-9.96%
Maase	N/A	N/A	N/A

Hyperion DeFi presently has a consensus target price of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher probable upside, equities analysts clearly believe Hyperion DeFi is more favorable than Maase.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Maase	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Maase had 3 more articles in the media than Hyperion DeFi. MarketBeat recorded 4 mentions for Maase and 1 mentions for Hyperion DeFi. Hyperion DeFi's average media sentiment score of 0.60 beat Maase's score of 0.51 indicating that Hyperion DeFi is being referred to more favorably in the media.

Company	Overall Sentiment
Hyperion DeFi	Positive
Maase	Positive

Summary

Hyperion DeFi beats Maase on 8 of the 14 factors compared between the two stocks.

How does Hyperion DeFi compare to Verb Technology?

Hyperion DeFi (NASDAQ:HYPD) and Verb Technology (NASDAQ:TONX) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Hyperion DeFi has a beta of 2.51, suggesting that its share price is 151% more volatile than the broader market. Comparatively, Verb Technology has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

25.8% of Hyperion DeFi shares are held by institutional investors. Comparatively, 7.2% of Verb Technology shares are held by institutional investors. 7.5% of Hyperion DeFi shares are held by insiders. Comparatively, 21.4% of Verb Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Hyperion DeFi has a net margin of 416.56% compared to Verb Technology's net margin of -497.15%. Hyperion DeFi's return on equity of -11.62% beat Verb Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-11.62%	-9.96%
Verb Technology	-497.15%	-60.82%	-59.56%

Hyperion DeFi has higher earnings, but lower revenue than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than Hyperion DeFi, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$810K	60.43	-$45.31M	-$6.53	N/A
Verb Technology	$12.78M	11.85	-$148.48M	-$1.04	N/A

In the previous week, Hyperion DeFi and Hyperion DeFi both had 1 articles in the media. Verb Technology's average media sentiment score of 1.79 beat Hyperion DeFi's score of 0.60 indicating that Verb Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Hyperion DeFi	Positive
Verb Technology	Very Positive

Hyperion DeFi presently has a consensus price target of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher probable upside, analysts clearly believe Hyperion DeFi is more favorable than Verb Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Verb Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Hyperion DeFi beats Verb Technology on 10 of the 14 factors compared between the two stocks.

How does Hyperion DeFi compare to Hillstream Biopharma?

Hyperion DeFi (NASDAQ:HYPD) and Hillstream Biopharma (NASDAQ:CNTN) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

25.8% of Hyperion DeFi shares are held by institutional investors. Comparatively, 1.2% of Hillstream Biopharma shares are held by institutional investors. 7.5% of Hyperion DeFi shares are held by insiders. Comparatively, 3.3% of Hillstream Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Hyperion DeFi presently has a consensus price target of $9.83, suggesting a potential upside of 211.90%. Given Hyperion DeFi's stronger consensus rating and higher possible upside, equities analysts plainly believe Hyperion DeFi is more favorable than Hillstream Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperion DeFi	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Hillstream Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hyperion DeFi has a beta of 2.51, indicating that its stock price is 151% more volatile than the broader market. Comparatively, Hillstream Biopharma has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market.

Hillstream Biopharma has higher revenue and earnings than Hyperion DeFi. Hillstream Biopharma is trading at a lower price-to-earnings ratio than Hyperion DeFi, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperion DeFi	$810K	60.43	-$45.31M	-$6.53	N/A
Hillstream Biopharma	$1.50M	99.61	-$35.92M	-$0.50	N/A

Hyperion DeFi has a net margin of 416.56% compared to Hillstream Biopharma's net margin of 0.00%. Hyperion DeFi's return on equity of -11.62% beat Hillstream Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperion DeFi	416.56%	-11.62%	-9.96%
Hillstream Biopharma	N/A	-20.06%	-15.90%

In the previous week, Hillstream Biopharma had 1 more articles in the media than Hyperion DeFi. MarketBeat recorded 2 mentions for Hillstream Biopharma and 1 mentions for Hyperion DeFi. Hillstream Biopharma's average media sentiment score of 0.86 beat Hyperion DeFi's score of 0.60 indicating that Hillstream Biopharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Hyperion DeFi	Positive
Hillstream Biopharma	Positive

Summary

Hyperion DeFi beats Hillstream Biopharma on 10 of the 16 factors compared between the two stocks.

How does Hyperion DeFi compare to KindlyMD?

KindlyMD (NASDAQ:NAKA) and Hyperion DeFi (NASDAQ:HYPD) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

KindlyMD currently has a consensus price target of $20.00, indicating a potential upside of 147.22%. Hyperion DeFi has a consensus price target of $9.83, indicating a potential upside of 211.90%. Given Hyperion DeFi's higher possible upside, analysts plainly believe Hyperion DeFi is more favorable than KindlyMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Hyperion DeFi	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

KindlyMD has a beta of 15.82, indicating that its share price is 1,482% more volatile than the broader market. Comparatively, Hyperion DeFi has a beta of 2.51, indicating that its share price is 151% more volatile than the broader market.

Hyperion DeFi has a net margin of 416.56% compared to KindlyMD's net margin of -1,067.93%. Hyperion DeFi's return on equity of -11.62% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-1,067.93%	-63.45%	-41.04%
Hyperion DeFi	416.56%	-11.62%	-9.96%

In the previous week, KindlyMD and KindlyMD both had 1 articles in the media. KindlyMD's average media sentiment score of 1.79 beat Hyperion DeFi's score of 0.60 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Very Positive
Hyperion DeFi	Positive

25.8% of Hyperion DeFi shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by company insiders. Comparatively, 7.5% of Hyperion DeFi shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Hyperion DeFi has lower revenue, but higher earnings than KindlyMD. Hyperion DeFi is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$39.89M	3.63	-$52.23M	-$35.85	N/A
Hyperion DeFi	$810K	60.43	-$45.31M	-$6.53	N/A

Summary

Hyperion DeFi beats KindlyMD on 8 of the 15 factors compared between the two stocks.

Get Hyperion DeFi News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HYPD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HYPD vs. The Competition

Export

Metric	Hyperion DeFi	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$48.95M	$28.31B	$13.59B	$12.94B
Dividend Yield	N/A	6.88%	6.07%	27.63%
P/E Ratio	-0.43	10.31	22.18	17.70
Price / Sales	54.49	343.25	489.59	76.22
Price / Cash	N/A	226.06	43.64	51.88
Price / Book	0.60	3.25	2.70	5.85
Net Income	-$45.31M	$1.11B	$1.32B	$380.67M
7 Day Performance	-16.47%	-2.60%	-0.48%	-4.97%
1 Month Performance	-13.15%	-1.28%	-2.13%	-6.95%
1 Year Performance	-58.30%	-9.89%	10.40%	-5.99%

Hyperion DeFi Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HYPD Hyperion DeFi	3.3056 of 5 stars	$2.84 -9.8%	$9.83 +246.0%	-59.0%	$48.95M	$810K	N/A	9
TROO TROOPS	0.1085 of 5 stars	$1.67 +4.4%	N/A	+13.4%	$204.01M	$17.10M	N/A	47	Trending News Upcoming Earnings Gap Up
MAAS Maase	0.4638 of 5 stars	$11.83 +2.5%	N/A	+323.2%	$188.33M	$109.05M	N/A	731	Short Interest Increase
TONX Verb Technology	1.5736 of 5 stars	$3.06 -1.3%	N/A	N/A	$168.51M	$12.78M	N/A	27	Positive News
CNTN Hillstream Biopharma	0.3338 of 5 stars	$2.02 -4.3%	N/A	N/A	$160.96M	$1.50M	N/A	12	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HYPD) was last updated on 10/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hyperion DeFi (HYPD) Competitors

HYPD vs. TROO, MAAS, TONX, CNTN, and NAKA

How does Hyperion DeFi compare to TROOPS?

Summary

How does Hyperion DeFi compare to Maase?

Summary

How does Hyperion DeFi compare to Verb Technology?

Summary

How does Hyperion DeFi compare to Hillstream Biopharma?

Summary

How does Hyperion DeFi compare to KindlyMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPD vs. The Competition

Hyperion DeFi Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hyperion DeFi (HYPD) Competitors

HYPD vs. TROO, MAAS, TONX, CNTN, and NAKA

How does Hyperion DeFi compare to TROOPS?

Do institutionals and insiders hold more shares of HYPD or TROO?

Which has better valuation & earnings, HYPD or TROO?

Do analysts prefer HYPD or TROO?

Is HYPD or TROO more profitable?

Which has more risk & volatility, HYPD or TROO?

Does the media prefer HYPD or TROO?

Summary

How does Hyperion DeFi compare to Maase?

Do institutionals & insiders believe in HYPD or MAAS?

Which has stronger valuation and earnings, HYPD or MAAS?

Which has more risk & volatility, HYPD or MAAS?

Is HYPD or MAAS more profitable?

Do analysts recommend HYPD or MAAS?

Does the media refer more to HYPD or MAAS?

Summary

How does Hyperion DeFi compare to Verb Technology?

Which has more risk and volatility, HYPD or TONX?

Do insiders and institutionals hold more shares of HYPD or TONX?

Is HYPD or TONX more profitable?

Which has better earnings and valuation, HYPD or TONX?

Does the media prefer HYPD or TONX?

Do analysts prefer HYPD or TONX?

Summary

How does Hyperion DeFi compare to Hillstream Biopharma?

Do insiders & institutionals believe in HYPD or CNTN?

Do analysts prefer HYPD or CNTN?

Which has more volatility and risk, HYPD or CNTN?

Which has preferable earnings & valuation, HYPD or CNTN?

Is HYPD or CNTN more profitable?

Does the media prefer HYPD or CNTN?

Summary

How does Hyperion DeFi compare to KindlyMD?

Do analysts prefer NAKA or HYPD?

Which has more risk and volatility, NAKA or HYPD?

Is NAKA or HYPD more profitable?

Does the media favor NAKA or HYPD?

Do insiders and institutionals believe in NAKA or HYPD?

Which has stronger valuation and earnings, NAKA or HYPD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HYPD vs. The Competition

Hyperion DeFi Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools